Dongbao Enterprise Group Co., Ltd Company Profile

16:49 EDT 19th September 2017 | BioPortfolio

Founded in 1985, Dongbao Enterprise Group Co., Ltd. is a conglomerate industrial group, with more than 20 subsidiaries, actively engaged in the field of pharmaceutical production and is now one of the pioneering manufacturers of recombinant biopharmaceuticals, especially recombinant human insulin.After years' development, the company retains its strength in the field of Traditional Chinese Medicine, and also becomes strong in the production of various types of pharmaceutical formulatios.
In Dongbao, innovative R&D programs, state-of-art technologic facilities, rigorous quality control systems, effectual marketing strategies as well as satisfactory after-sales services have been integrated into a well organized business operation syste.
Since its establishment, Dongbao Group has demonstrated its commitment to improving people's life and adding good value to the society. Due to its achievements, Dongbao is enjoying a sound international recognition today and has established tight partnerships with companies from various countries and will endeavor to further its international collaboration.
In human history, 18 years may not be a long time. What Dongbao has achieved in such a short time is becoming a well established pharmaceutical and biotech group with advanced technological capability, immense growing potential and well defined future prospects.


Room 1906~1909, Shanghai Times Square, 93 Huaihai Road


Phone: 86 21 63910001
Fax: 86 21 63910056

News Articles [932 Associated News Articles listed on BioPortfolio]

Watson-Marlow Fluid Technology Group UK Businesses Honoured with Queen’s Award for Enterprise: International Trade 2017 on Her Majesty’s 91st birthday

Business Secretary Greg Clark has named the UK businesses within the Watson-Marlow Fluid Technology Group as winners of the Queen’s Awards for Enterprise in celebration of Her Majesty The Queen&...

Eventus Solutions Group Adds Greg Weber as Enterprise Communications Consulting Practice Leader

DENVER, CO--(Marketwired - September 05, 2017) -Eventus Solutions Group, a nationally recognized consulting and managed services firm focused on optimizing customer engagement, today Read more...

China Healthcare Group Bolstering R&D with Cloud Implementation

NewsFosun Pharma selects Medidata’s unified platform for clinical development in China. Healthcare group adopts cloud technology to bring operational efficiencies to its R&D programs.

Altec Joins The Resource Group as a Bronze Sponsor at RG Connect 2017

Laguna Hills, CA (PRWEB) May 10, 2017 Altec Products, Inc., a leader in enterprise document management and workflow solutions, tod...

Science Exchange launches updated enterprise dynamic report tool

Demonstrating the company’s commitment to support its clients’ growth plans by optimizing data aggregation and business intelligence, Science Exchange, a secure platform for outsourced research a...

Outsourcing-Pharma’s Hiring and Firing Roundup August ‘17

This month’s roundup features LabCorp newly created enterprise-wide chief medical officer position and two new hires at WIRB-Copernicus Group’s eCOA arm.

Allscripts Acquires McKesson’s Enterprise Information Solutions for $185M

Allscripts has entered into an agreement to acquire McKesson Corporation’s hospital and health system IT business, Enterprise Information Solutions for $185M in cash. The Enterprise Information Solu...

Forbes Names The De Angelis Group Among the Top 250 Best Executive Recruiting Firms in 2017

Forbes worked with analytics firm Statista to compile list of over 4,000 executive recruiting companies and ranked The De Angelis Group as one of the Top 250. Scottsdale, Arizona (PRWEB) May 19, 2017 ...

PubMed Articles [2669 Associated PubMed Articles listed on BioPortfolio]

Comparison and application of two risk assessment methods for occupational lead exposure risk classification in a lead-acid battery enterprise.

Objective: To apply and compare two risk assessment methods for occupational lead exposure risk classification in a lead-acid battery enterprise. Methods: In April 2013, an occupational health survey ...

Making the Paradigm Shift from Siloed Population Health Management to an Enterprise-Wide Approach.

Health systems across the United States have started their journeys toward population health management and the future of accountable care. Models of population health management include patient-cente...

Therapeutic effect of enterprise stent-assisted embolization for very small ruptured intracranial aneurysms.

Enterprise stent has been widespread used in wide-necked intracranial aneurysms and good efficacy has been achieved, but there are few reports on its applications in very small ruptured intracranial a...

Strengthening the US Medical Countermeasure Enterprise for Biological Threats.

Transcanalicular laser-assisted dacryocystorhinostomy with diode laser.

This article compares the efficacy of transcanalicular laser assisted dacryocystorhinostomy (TL DCR) with conventional external dacryocystorhinostomy (Ex DCR). All patients were randomly divided into ...

Clinical Trials [3128 Associated Clinical Trials listed on BioPortfolio]

Enterprise Stent Implantation in the Treatment of Carotid Artery Stenosis With Ischemic Stroke

To investigate the long-term effects of intracranial implantation of Enterprise stent system versus antiplatelet medication on neurologic deficits, daily living abilities, and carotid arte...

The ENTERPRISE Study - Study of the Enterprise Self-Expanding Stent System

To evaluate the safety and feasibility of the Cordis Neurovascular Self-Expanding Stent System to facilitate endovascular coil embolization of wide neck saccular intracranial aneurysms. ...

The Registry to Study Safety and Performance of the CORDIS Vascular Reconstruction Device and Delivery System

The objective of the registry is to evaluate the real world safety and performance of the CORDIS ENTERPRISE™ Vascular Reconstruction Device and Delivery System (VRD) to facilitate endova...

Study of the Enterprise Self-Expanding Stent System With Endovascular Coil Embolization of Wide- Neck Saccular Intracranial Artery Aneurysms

Cordis Self Expanding Stent for use with embolic coils for the treatment of wide-neck, intracranial, saccular aneurysms arising from a parent vessel

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Companies [2277 Associated Companies listed on BioPortfolio]

Dongbao Enterprise Group Co., Ltd

Founded in 1985, Dongbao Enterprise Group Co., Ltd. is a conglomerate industrial group, with more than 20 subsidiaries, actively engaged in the field of pharmaceutical production and is now one of the...


Coveo is a leader in enterprise search-powered solutions. The Coveo Enterprise Search Platform and Customer Information Access Solutions help organizations generate value from information and knowled...

Siemens Enterprise Communications Group

Public Service Enterprise Group (PSEG)


ServiceNow is the enterprise IT cloud company. We focus on transforming enterprise IT by automating and standardizing business processes and consolidating IT across the global ent...

More Information about "Dongbao Enterprise Group Co., Ltd" on BioPortfolio

We have published hundreds of Dongbao Enterprise Group Co., Ltd news stories on BioPortfolio along with dozens of Dongbao Enterprise Group Co., Ltd Clinical Trials and PubMed Articles about Dongbao Enterprise Group Co., Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dongbao Enterprise Group Co., Ltd Companies in our database. You can also find out about relevant Dongbao Enterprise Group Co., Ltd Drugs and Medications on this site too.

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record